Instil Bio
30 hedge funds and large institutions have $43.5M invested in Instil Bio in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
0.31% less ownership
Funds ownership: 65.35% → 65.04% (-0.31%)
3% less funds holding
Funds holding: 31 → 30 (-1)
5% less capital invested
Capital invested by funds: $45.9M → $43.5M (-$2.37M)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$458K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.7K |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$6.75K |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$5.4K |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$223K |
| 2 |
Squarepoint
New York
|
-$188K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$167K |
| 4 |
Renaissance Technologies
New York
|
-$108K |
| 5 |
Two Sigma Advisers
New York
|
-$15.1K |
TIL Hedge Fund Activity: Q2 2024 in Review
30 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2024, worth a combined $43.5M — down 5.2% from $45.9M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TIL and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 7 added.
The largest buyer was BML Capital Management, adding an estimated $458K. The largest seller was Two Sigma Investments, cutting an estimated $223K.
- 30 institutional investors held Instil Bio (TIL) as of Q2 2024, down from 31 in Q1 2024.
- Funds reported $43.5M of Instil Bio stock for Q2 2024, down 5.2% quarter-over-quarter.
- 3 funds opened new Instil Bio positions in Q2 2024 and 4 closed out, a net change of -1 holder.
- The largest Instil Bio buyer in Q2 2024 was BML Capital Management, an estimated $458K added.
- The largest Instil Bio seller in Q2 2024 was Two Sigma Investments, an estimated $223K sold.
Based on aggregated 13F filings for Q2 2024.